PHARMACOLOGICAL REPORTS, cilt.67, ss.846-853, 2015 (SCI İndekslerine Giren Dergi)
Background: Diabetes is a major public health problem that is rapidly increasing in prevalence. In this study, the effects of sitagliptin, a dipeptidyl peptidase-4 inhibitor, were examined on newborn diabetic rat model.